Transit Alert: SEPTA is cutting bus, subway, and rail service across Philadelphia. These changes may affect patients, visitors, and staff traveling to and from Fox Chase Cancer Center locations. Read full update.
Sameera Kumar, MD
Clinical Locations
-
Fox Chase Cancer Center333 Cottman Avenue
Philadelphia, PA 19111
Phone: 888-369-2427
Assistant Professor
Specialties
- Radiation Oncology ;
- Thoracic Radiation Oncology
Areas of Expertise
Esophageal Cancer, Mesothelioma, Lung Metastases, Lung Cancer, Thymoma
Distinctions
Educational Background
- Department of Radiation Oncology, University of Kentucky, Lexington, KY, July 2014-June 2018
- Resident in Radiation Oncology, 2014-18
- Chief Resident, 2017-18
- PhD candidate, Clinical and Translational Science, University of Kentucky, Lexington, KY, January 2015- Present
- MD, West Virginia University School of Medicine, Morgantown, WV, 2013
Certifications
- American Board of Radiology - Radiation Oncology
Honors & Awards
- Philadelphia Magazine Top Doctors, 2024
Tiffany Fagnani
- Lung Cancer
I am 40 years old and currently live in Mechanicsburg, Pennsylvania. Although I work as a case manager for an insurance company now, I was previously employed as a full-time nurse. I have always been a busy person with plenty on my plate, so when I started feeling tired and losing weight, I thought it was caused by the stress of my daily routine.
It wasn’t until July 2017 that I couldn’t ignore my symptoms any longer. When I developed a migraine and felt a tremor in my arm and eye, I knew I was about to lose consciousness. I immediately called 911.
Selected Publications
Kumar, S; Hall, L; Li, X; Downes, L; Shearer, A; Shelton, B; Gerring, S; McGarry, R. “Comparing Dosimetric Parameters and Clinical outcomes among different SBRT modalities.” IJROBP. Submitted.
Kumar, S; Feddock, J; Li, X; Shearer, A; Hall, L; Shelton, B; Arnold, S; McGarry, M. “An Update of a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.” IJROBP. Accepted- In Press. DOI: http://dx.doi.org/10.1016/j.ijrobp.2017.07.036
Kumar, S; Higgins, K; McGarry, R. “Emerging Therapies for Stage III Non-Small Cell Lung Cancer: Stereotactic Body Radiation Therapy and Immunotherapy.” Frontiers of Oncology. Front. Oncol., 04 September 2017.
DOI: https://doi.org/10.3389/fonc.2017.00197
Verma, V; Shostrom, V; Kumar, S; Zhen, W; Hallemeier, C, Braunstein, S; Holland, J; Harkenrider, M; Ishkhanian, A; Neboori, H; Jabbour, S; Attia, A; Lee, P; Alite, F; Walker, J; Stahl, J; Wang, K; Bingham, B; Hadzitheodorou, C; Decker, R; McGarry, R; Simone, C. “Multi-Institutional Experience of Stereotactic Body Radiotherapy for Large (≥5 Centimeter) Non-Small Cell Lung Tumors.” Cancer. September 9, 2016. PubMed
Dong, L; Kudrimoti, M; Irwin, D; Chen, L; Kumar, S; Shang, Y; Huang, C; Johnson, E; Stevens, S; Shelton, B; Yu, G. "Diffuse optical measurements of head and neck tumor hemodynamics for early prediction of chemoradiation therapy outcomes," J. Biomed. Opt. 21(8), 085004 (2016), doi: 10.1117/1.JBO.21.8.085004.
Kumar, SS; Stockham, AL; Chao, ST; Ahluwalia, MS; Suh, JH. “Radiation necrosis: now you see it, now you don’t." Applied Radiology. February 2013.
Additional Publications
Dr. Kumar on PubMed
